Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.
bioscience. questions. answered.

In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Articles, Blog

Protein Analysis Products: Effect of U.S. Sequester

Mason Brooks

25th Nov, 2013

Articles, Blog, Polls

0

In October 2013, we polled users of protein analysis products in the U.S. to understand how, if at all, budget sequestration has affected their lab’s purchase of protein analysis products.  Results reveal that both non-profit and for-profit researchers are impacted by budget sequestration as approximately 56% of non-profit and 29% of for-profit respondents indicated budget sequestration has definitely affected…

read more >

RNA Expression Profiles Fuel New Tuberculosis Diagnostic

Mason Brooks

25th Oct, 2013

Articles, Blog, News

0

In places where controlling tuberculosis (TB) is a concern, there is an urgent need for simple, inexpensive diagnostics that can identify active TB, particularly in the context of HIV infection. In a recent paper (PLoS Medicine, October 22, 2013), researchers discovered that a unique RNA transcriptional signature found in whole blood could distinguish TB from other diseases including HIV…

read more >

Optimized Gene Expression Analysis Aids Drug Development

percepta

16th Oct, 2013

Articles, Blog

0

During drug development, it’s critical to monitor cellular responses to promising compounds, which includes keeping tabs on the activities of various gene promoters. Researchers from the RIKEN Center for Life Science Technologies report a new method to accomplish that, using the advanced gene expression analysis method CAGE followed by single-molecule sequencing.

Click to enlarge. Original image…

read more >

NGS in the Clinic: NIH Awards $8M Grant for Pre-Conception Whole Genome Sequencing Study

percepta

26th Jul, 2013

Articles, Blog

0

The Kaiser Permanente Center for Health Research was awarded $8.1 million from the National Institutes of Health (NIH) to conduct a novel clinical trial using whole genome sequencing to test women and their partners, before they actually conceive, for mutations that could cause rare, but serious diseases in their offspring.

The project is part of the Clinical Sequencing Exploratory Research…

read more >

In the Bioprocessing World it’s all about Traceability, Transparency and Support

percepta

6th Jun, 2013

Articles

0

Biopharmaceutical companies, being in a regulated industry, have always been focused on meeting quality requirements and controlling their supply chain. However, in the past few years they have had to deal with increasingly stringent regulatory demands to demonstrate that they are in control of not only their internal manufacturing processes, but the manufacturing processes of their raw material vendors…

read more >

Communication Channels for Immunology Researchers

percepta

22nd Feb, 2013

Articles, Blog

0

If you are looking for ways to communicate with researchers that identify themselves as immunology researchers, some of Percepta’s latest data suggests the popularity of various information sources spans a pretty broad spectrum. Search engines still rank high as a place immunologist look for product information. Also popular are peer recommendations, journal citations and company web sites, with more…

read more >

How Many “Omics” Does it Take to Study a Single Cell?

percepta

18th Feb, 2013

Articles, Blog

0

As has been shown again and again, seemingly homogeneous cell populations often consist of more than one cell type, which can confound research results. Single-cell research offers a bottom-up approach to circumventing such unwanted cellular heterogeneity. As a testament to its potential promise, the NIH has committed ~$90 million over 5 years to single cell analysis research. At Percepta,…

read more >

Three Trends in Biotools Markets for 2011

percepta

26th Jan, 2011

Articles, Blog

0

It was a hectic close to 2010 which shows us that biotools industry is alive and healthy! Though the future economic environment for the globe remains uncertain and public funding levels for life sciences in the US may plataue of or even dip in 2011, there were several things that we noticed at Percepta that we believe will be…

read more >

Bio-tool Companies Aim at Better Offering for Drug Development

percepta

30th Sep, 2010

Articles, Blog

0

In the recent few quarters Percepta has experienced an increase in demand for studies relating to better serving the pharmaceutical industry. The focus of the studies have varied considerably but the trend is evident. This tells us bio-tools companies are getting more serious about tailoring an offering to the drug discovery and development market that will resonate with the…

read more >

Copyright © 2017 Percepta Associates Inc. All rights reserved. Terms & Conditions.Designed by Audacity